Latest Proton therapy Stories
PARIS, Nov. 8, 2010 /PRNewswire/ -- One of Europe's leading hospitals offering brachytherapy treatments for cancer patients has commenced treatments using three advanced computer-controlled afterloader devices and a full suite of planning software from Varian Medical Systems (NYSE: VAR).
PALO ALTO, Calif., Nov. 5, 2010 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is scheduled to present at Lazard Capital Markets Healthcare Conference at 9:30 a.m. ET on Wednesday, November 17th at the St.
JEDDAH, Saudi Arabia, Nov.
HYDERABAD, India, Nov. 2, 2010 /PRNewswire/ -- Advanced cancer treatments across India will become more widely available with the order of four state-of-the-art Varian Medical Systems (NYSE: VAR) medical linear accelerators by Global Hospitals, one of the nation's leading private hospital groups.
When treating prostate cancer with radiation therapy, side effects such as urinary problems and rectal pain and bleeding are a concern, as is impact on the patient's overall quality of life.
SAN DIEGO, Nov.
SAN DIEGO, Nov.
The P-CURE Solution: Maximizing the Potential of Proton Therapyâ€” Significant Cost Reduction for Multi-Room Centers The reality of broadly accessible proton therapy, a minimally invasive treatment for cancer with substantially less treatment related side effects, has come a step closer.
PALO ALTO, Calif. and SPRINGFIELD, Va. Oct. 29 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR) today announced that CURE Foundation has placed an order for five Varian TrueBeam(TM) systems for stereotactic radiosurgery and radiation therapy.
SAN DIEGO, Oct. 28 /PRNewswire/ -- ASTRO Booth # 201 -- Varian Medical Systems (NYSE: VAR) will highlight its new TrueBeam(TM) system for fast, powerful and efficient cancer treatments at the 52nd annual meeting of the American Society for Radiation Oncology (ASTRO) meeting in San Diego next week.
- an ornament or knob in the shape of a flower